Director, External Corporate Communications

Responsibilities

• Develop communication strategies and plans that effectively communicate corporate and product stories to external audiences.
• Partner and coordinate with the executive team and other functional team members in the overall stewardship of the corporate brand, positioning and messaging.
• Own the process of creating and update company's overarching narrative and message architecture, ensuring consistency across the website, investor materials, social channels, commercial and medical communications.
• Navigate the process of obtaining approval for the Corporate Branding strategy and content by the Executive Team and other key stakeholder
• Develop and draft external communications materials, including corporate website content, press releases, R&D Day and investor materials, working with the appropriate functional subject matter experts. Where materials contain scientific, clinical or medical content, work closely with the CMO and designated Clinical/Medical subject matter experts, who retain accountability for the scientific and medical content and interpretation.
• Contribute to the production of press releases, earnings releases, corporate updates, and clinical trial milestone announcements, in close coordination with the CFO, General Counsel, and CEO.
• Prepare briefing materials for quarterly earnings calls, investor conference presentations, and the annual report / MD&A narrative, working with IR counsel and the executive team.
• Develop talking points, Q&A documents across investor, media, and public forums, ensuring message discipline.
• Support the Investor Relations function on positioning materials, including the corporate deck, fact sheet, and website content, ensuring consistent, non-promotional, compliant messaging across all investor touchpoints.
• Coordinate with IR the external messaging calendar around clinical catalysts, ensuring alignment with continuous disclosure obligations and coordination with the company's disclosure committee.

Requirements

• Bachelors’ degree in Life Sciences or related field; additional communications and/or journalism qualifications are an asset.
• 8–10+ years of progressively senior communications, investor relations, or public relations experience, with at least 5 years in biotech, pharma, or life sciences.
• Understanding of the healthcare ecosystem, including clinical workflows, regulatory landscapes, reimbursement environments, and therapeutic areas (e.g., GI, Immunology and/or specialty therapeutics).
• Excellent writing and editing skills, and the ability to translate clinical and scientific data into clear, accurate, non-promotional external messaging.
• Experience with developing and executing communication strategies and tactics.
• Demonstrated experience in public-company investor relations and financial communications, including press release drafting, disclosure coordination, and earnings-related materials.
• Working knowledge of Canadian and/or U.S. securities disclosure requirements and familiarity working with a disclosure committee.
• Strong relationship-management skills with analysts, and agency partners; sound judgment under time pressure and during high-stakes or sensitive situations.
• Proven ability to work with and effectively influence leadership teams while operating in a fast-paced, entrepreneurial, decisive/deadline-oriented environment, heavily regulated industry; strong interpersonal skills and ability to work with others in a positive, collaborative manner.
• Excellent planning and organizational skills, with a keen ability to multi-task.

Preferred

• Highly motivated self-starter with strong initiative in identifying operational improvements.
• Clear communicator capable of presenting to senior management, and key external stakeholders.
• Proactive problem-solver who can troubleshoot equipment issues and safety concerns independently.
• Excellent organizational and time management skills to juggle multiple priorities.
• Continuous learner committed to staying current with development in Eupraxia’s strategic areas of interest (GI disease and EoE).

Benefits

• competitive benefits package.